Myriad Says Bioinformatics Central to Rice Genome Success; Additional Sequence Project Underway | GenomeWeb

Myriad Genetics’ in-house bioinformatics capabilities played a key role in completing the sequence of the rice genome six months ahead of schedule, under budget, and with 99.5 percent accuracy, according to Sudhir Sahasrabudhe, executive vice president for research and development for Myriad.

Myriad, in collaboration with Syngenta subsidiary Torrey Mesa Research Institute, completed the sequencing in 14 months, netting Myriad a $3 million cash bonus.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.